2.31. Analysis.

Comparison 2 Rivastigmine oral capsules (1 to 4 mg/day or 6 to 12 mg/day in two divided doses) versus placebo, Outcome 31 at least one adverse event of insomnia by the end of titration period.

Comparison 2 Rivastigmine oral capsules (1 to 4 mg/day or 6 to 12 mg/day in two divided doses) versus placebo, Outcome 31 at least one adverse event of insomnia by the end of titration period.